Stockscreener 앱 받기
3.38
0.59%
0.010
전일 마감가:
$3.37
열려 있는:
$3.39
하루 거래량:
167
Relative Volume:
0.00
시가총액:
$57.42M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.87%
1개월 성능:
-7.38%
6개월 성능:
-10.08%
1년 성능:
+0.00%
1일 변동 폭
$3.39
$3.39
1주일 범위
$3.30
$3.53
52주 변동 폭
$2.88
$6.00
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MURA | 3.39 | 57.42M | 0 | 0 | 0 | 0.00 |
| VRTX | 448.31 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 742.12 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.91 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.68 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.52 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - The Manila Times
Mural Oncology's Cancer Drug Shows 33% Response Rate in Melanoma Trial Data | MURA Stock News - StockTitan
HC Wainwright Raises Earnings Estimates for Mural Oncology - Defense World
HC Wainwright Predicts Stronger Earnings for Mural Oncology - MarketBeat
MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan
Armistice Capital, LLC Increases Stake in Mural Oncology PLC - GuruFocus.com
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress - The Manila Times
Mural Oncology plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Mural Oncology Reports 38% Lower Net Loss, Hits Trial Enrollment Milestones in Q3 | MURA Stock News - StockTitan
HC Wainwright Reaffirms "Buy" Rating for Mural Oncology (NASDAQ:MURA) - MarketBeat
Mural Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times
Mural Oncology (MURA) to Present at Major Healthcare Investor Conferences | MURA Stock News - StockTitan
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Mural Oncology Reports Promising Cancer Trial Data, Plans Key 2025 Readouts | MURA Stock News - StockTitan
Vanguard Group Inc's Strategic Reduction in Mural Oncology PLC H - GuruFocus.com
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada
Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat
Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com
Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat
HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat
Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat
H.C. Wainwright initiates coverage on Mural Oncology stock with Buy rating - Investing.com UK
167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat
232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World
Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat
Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World
Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes
Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World
1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat
Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan
Mural Oncology appoints new board member amid growth phase - Investing.com
Mural Oncology appoints new director and audit chair - Investing.com
Mural Oncology appoints new director and audit chair By Investing.com - Investing.com UK
Mural Oncology Appoints Sachiyo Minegishi To Board - citybiz
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi - EIN News
Mural Oncology appoints new board member amid growth phase By Investing.com - Investing.com South Africa
Primecap Management Co. CA Purchases Shares of 235,551 Mural Oncology plc (NASDAQ:MURA) - MarketBeat
Primecap Management Co. CA Buys New Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Acadian Asset Management LLC Takes $998,000 Position in Mural Oncology plc (NASDAQ:MURA) - MarketBeat
Acadian Asset Management LLC Buys Shares of 318,536 Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - ForexTV.com
We Think Mural Oncology (NASDAQ:MURA) Needs To Drive Business Growth Carefully - Yahoo Finance
Mural Oncology to Present at Two Upcoming Investor Conferences - ForexTV.com
Mural Oncology plc (NASDAQ:MURA) Sees Significant Decrease in Short Interest - MarketBeat
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - BioSpace
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Mural Oncology Plc 주식 (MURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 07 '24 |
Sale |
3.33 |
5,069 |
16,880 |
67,949 |
0.42%
0.16%
자본화:
|
볼륨(24시간):